Intermezzo

Indicated For

insomnia, middle-of-the-night awakening

About This Medication

# Viatris Patient Assistance Program: How to Get Intermezzo (Zolpidem Tartrate) at Low or No Cost ## About Intermezzo Intermezzo is a prescription sleep aid containing zolpidem tartrate, designed specifically for people who wake up in the middle of the night and have difficulty falling back asleep. Unlike Ambien, which is taken before bedtime, Intermezzo is a sublingual (under-the-tongue) tablet taken only when needed during the night. The medication works by increasing GABA activity in the brain to create a calming effect, helping you return to sleep quickly. Intermezzo is FDA-approved for as-needed treatment when a middle-of-the-night awakening is followed by difficulty returning to sleep, provided you have at least 4 hours of sleep remaining before your planned wake time. The recommended dose is 1.75 mg for women and 3.5 mg for men. ## Who Qualifies for Assistance Viatris's patient assistance program helps uninsured and underinsured Americans access Intermezzo at reduced or no cost. You may qualify if you: - Are a U.S. citizen or permanent resident - Have a valid prescription from your healthcare provider - Meet the program's income eligibility requirements - Cannot afford your medication through other means The program works alongside existing health insurance coverage, meaning you can apply even if you have insurance. There are no medication tiers, copays, or deductibles through the assistance program. ## Income Eligibility While specific income thresholds for the Viatris Intermezzo program were not available in current resources, most manufacturer patient assistance programs use federal poverty level (FPL) guidelines. Typical eligibility ranges from 100% to 400% of the federal poverty level, depending on household size. | Household Size | Approximate Annual Income Range* | |---|---| | 1 person | $14,000–$56,000 | | 2 people | $18,000–$72,000 | | 3 people | $23,000–$92,000 | | 4 people | $28,000–$112,000 | *These are estimates based on 2026 federal poverty guidelines. Contact the program directly for exact thresholds. ## Insurance Requirements You do not need to be uninsured to qualify for this patient assistance program. The program is designed to work alongside any existing health insurance coverage you may have. Whether you have Medicare, Medicaid, private insurance, or no insurance, you can apply. The program does not have medication tiers, copays, or deductibles. ## How to Apply While specific application details for the Viatris Intermezzo program were not fully detailed in available resources, the typical process for manufacturer patient assistance programs includes these steps: 1. **Gather Required Information**: Have your Social Security number, income documentation, and insurance information (if applicable) ready. 2. **Contact the Program**: Call the program's patient assistance line or visit their website to begin your application. You can also ask your healthcare provider or pharmacist to help you apply. 3. **Complete the Application**: Provide personal, financial, and medical information. Be honest and accurate—this helps determine your eligibility. 4. **Submit Documentation**: You may need to provide proof of income (tax returns, pay stubs, or benefit statements) and a copy of your prescription. 5. **Wait for Approval**: Program advocates will review your application and determine eligibility within a specified timeframe. 6. **Receive Your Medication**: Once approved, the program will coordinate with your pharmacy or mail the medication directly to you. ## Timeline and Delivery Based on industry standards for manufacturer patient assistance programs, you can typically expect: - **Initial Eligibility Determination**: Within 48 hours to 2 weeks - **First Medication Delivery**: 2 to 4 weeks after approval (once all paperwork is received) - **Ongoing Refills**: Managed automatically month-to-month - **Annual Reauthorization**: Required yearly to maintain enrollment Delivery is typically handled through mail directly to your home or to your pharmacy, depending on the program's process. ## What You'll Need to Apply Common documentation required for patient assistance programs includes: - Valid prescription for Intermezzo from your healthcare provider - Proof of U.S. citizenship or permanent residency - Proof of income (recent tax return, pay stubs, or benefit statements) - Proof of insurance status (insurance card or letter stating you're uninsured) - Government-issued photo ID - Contact information (phone number and mailing address) Contact the program directly to confirm the exact documents needed for your situation. ## What If Your Application Is Denied? If you don't qualify for the Viatris program, consider these alternatives: - **Ask about generic zolpidem**: Generic versions of zolpidem are significantly less expensive than brand-name Intermezzo and may be covered by insurance or available at lower cost through discount programs. - **Explore other patient assistance programs**: Organizations like Prescription Hope work with multiple manufacturer programs and may find alternative assistance options. - **Check pharmacy discount programs**: GoodRx, SingleCare, and similar services offer discounted pricing on many medications. - **Talk to your doctor**: Your healthcare provider may have samples or know of other resources to help you access medication. - **Contact 211**: Dial 211 or visit 211.org to find local health and human services resources in your area. ## Important Disclaimer This guide provides general information about patient assistance programs for Intermezzo. Specific eligibility requirements, income thresholds, application procedures, and program benefits vary and may change. For accurate, up-to-date information about the Viatris patient assistance program for Intermezzo, contact the program directly or speak with your healthcare provider or pharmacist. This information is not a guarantee of eligibility or enrollment. Always consult with your healthcare provider before starting, stopping, or changing any medication.

Program information last verified: March 30, 2026